LON:N4P - N4 Pharma Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 8.26
▼ -0.345 (-4.01%)

This chart shows the closing price for N4P by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New N4 Pharma Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for N4P and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for N4P

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for N4 Pharma in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 8.26.

This chart shows the closing price for N4P for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 investment analysts is to n/a stock in N4 Pharma. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/1/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/30/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/25/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/5/2018Beaufort SecuritiesReiterated RatingSpeculative Buy
12/22/2017Beaufort SecuritiesReiterated RatingSpeculative BuyGBX 12
11/30/2017Beaufort SecuritiesReiterated RatingSpeculative BuyGBX 12
11/8/2017Beaufort SecuritiesReiterated RatingSpeculative BuyGBX 12
10/11/2017Beaufort SecuritiesReiterated RatingSpeculative BuyGBX 12
9/26/2017Beaufort SecuritiesReiterated RatingSpeculative BuyGBX 12
7/27/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
7/3/2017Beaufort SecuritiesReiterated RatingSpeculative Buy
(Data available from 7/25/2016 forward)
N4 Pharma logo
N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. The company has a research collaboration with Nanomerics Limited to focus on the different formulations of Nuvec delivery system. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Read More

Today's Range

Now: GBX 8.26
Low: 8.26
High: 8.90

50 Day Range

MA: GBX 8.61
Low: 7.90
High: 10.11

52 Week Range

Now: GBX 8.26
Low: 4.43
High: 16

Volume

531,583 shs

Average Volume

2,039,439 shs

Market Capitalization

£14.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of N4 Pharma?

The following sell-side analysts have issued stock ratings on N4 Pharma in the last year:
View the latest analyst ratings for N4P.

What is the current price target for N4 Pharma?

0 Wall Street analysts have set twelve-month price targets for N4 Pharma in the last year. has the lowest price target set, forecasting a price of £100,000 for N4 Pharma in the next year.
View the latest price targets for N4P.

What is the current consensus analyst rating for N4 Pharma?

N4 Pharma currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for N4P.

What other companies compete with N4 Pharma?

How do I contact N4 Pharma's investor relations team?

N4 Pharma's physical mailing address is Weston House, 1 Bradgate Park View, DERBY, DE73 5UJ, United Kingdom. The company's listed phone number is +44-1332-690061. The official website for N4 Pharma is www.n4pharma.com.